{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T10:53:14Z","timestamp":1675853594148},"reference-count":42,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2222\/jsv.62.57","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T22:44:40Z","timestamp":1368053080000},"page":"57-66","source":"Crossref","is-referenced-by-count":8,"title":["Poliovirus Vaccine"],"prefix":"10.2222","volume":"62","author":[{"given":"Hiroyuki","family":"SHIMIZU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1"},{"key":"2"},{"key":"3"},{"key":"4"},{"key":"5","unstructured":"5)The Global Polio Eradication Initiative: Wild Poliovirus 2007-2012 (http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Data&Monitoring\/Wild_poliovirus_list_2007_2012_17Apr.pdf), Data in WHO HQ as of 17 Apr, 2012."},{"key":"6","unstructured":"6)The Global Polio Eradication Initiative: Polio in India: Fact Sheet. (http:\/\/www.polioeradication.org\/Portals\/0\/Document\/InfectedCountries\/India\/Polio_In_India_Factsheet.pdf), 2012."},{"key":"7","unstructured":"7)Independent Monitoring Board of the Global Polio Eradication Initiative: Report of the independent Monitoring Board of the Global Polio Eradication Initiative, February 2012. (http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Aboutus\/Governance\/IMB\/5IMBMeeting\/IMBReport_January2012.pdf), 2012."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8)Wassilak S, Pate MA, Wannemuehler K, Jenks J, Burns C, Chenoweth P, Abanida EA, Adu F, Baba M, Gasasira A, Iber J, Mkanda P, Williams AJ, Shaw J, Pallansch M, Kew O: Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis 203: 898-909, 2011.","DOI":"10.1093\/infdis\/jiq140"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9)Outbreak of poliomyelitis in Tajikistan in 2010: risk for importation and impact on polio surveillance in Europe? Euro Surveill 15: 152010, 2010.","DOI":"10.2807\/ese.15.17.19558-en"},{"key":"10","unstructured":"10)Outbreak news. Confirmed international spread of wild poliovirus from Pakistan. Wkly Epidemiol Rec 86: 437-438, 2011."},{"key":"11","unstructured":"11)WHO in the Western Pacific. Wild poliovirus in China, 16 April 2012 update (http:\/\/www.wpro.who.int\/entity\/immunization\/news\/wild_poliovirus_China\/en\/index.html), 2012"},{"key":"12"},{"key":"13"},{"key":"14","unstructured":"14)Doi Y, Abe S, Yamamoto H, Horie H, Ohyama H, Satoh K, Tano Y, Ota Y, Miyazawa M, Wakabayashi K, Hashizume S: Progress with inactivated poliovirus vaccines derived from the Sabin strains. Dev Biol (Basel)"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15)Simizu B, Abe S, Yamamoto H, Tano Y, Ota Y, Miyazawa M, Horie H, Satoh K, Wakabayashi K: Development of inactivated poliovirus vaccine derived from Sabin strains. Biologicals 34: 151-154, 2006.","DOI":"10.1016\/j.biologicals.2006.02.010"},{"key":"16"},{"key":"17"},{"key":"18"},{"key":"19"},{"key":"20","unstructured":"20)The Global Polio Eradication Initiative: Developing affordable inactivated polio vaccine. (http:\/\/www.polioeradication.org\/Research\/AffordableIPV.aspx),2012."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21)Dowdle WR, Wolff C: Post-eradication poliovirus facility-associated community risks. Biologicals 34: 127-132, 2006.","DOI":"10.1016\/j.biologicals.2006.03.003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22)Mulders MN, Reimerink JH, Koopmans MP, van Loon AM, van der Avoort HG: Genetic analysis of wild-type poliovirus importation into The Netherlands (1979-1995). J Infect Dis 176: 617-624, 1997.","DOI":"10.1086\/514081"},{"key":"23","unstructured":"23)Deshpande JM, Nadkarni SS, Siddiqui ZA: Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003. Indian J Med Res 118: 217-223, 2003."},{"key":"24","unstructured":"24)WHO: WHO global action plan for laboratory containment of wild polioviruses, Second edition. (http:\/\/www.polioeradication.org\/content\/publications\/who-vb-03-729.pdf), 2004."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25)Liao G, Li R, Li C, Sun M, Li Y, Chu J, Jiang S, Li Q: Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial. J Infect Dis 205: 237-243, 2012.","DOI":"10.1093\/infdis\/jir723"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26)Verdijk P, Rots NY, Bakker WA: Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains. Expert Rev Vaccines 10: 635-644, 2011.","DOI":"10.1586\/erv.11.51"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27)Bakker WA, Thomassen YE, Van't Oever AG, Westdijk J, van Oijen MG, Sundermann LC, Van't Veld P, Sleeman E, van Nimwegen FW, Hamidi A, Kersten GF, van den Heuvel N, Hendriks JT, van der Pol LA: Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. Vaccine 29: 7188-7196, 2011.","DOI":"10.1016\/j.vaccine.2011.05.079"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28)Westdijk J, Brugmans D, Martin J, van't Oever A, Bakker WA, Levels L, Kersten G: Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines. Vaccine 29: 3390-3397, 2011.","DOI":"10.1016\/j.vaccine.2011.02.085"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29)ten Have R, Thomassen YE, Hamzink MR, Bakker WA, Nijst OE, Kersten G, Zomer G: Development of a fast ELISA for quantifying polio D-antigen in in-process samples. Biologicals 40: 84-87, 2012.","DOI":"10.1016\/j.biologicals.2011.11.004"},{"key":"30"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31)Fine PE: Herd immunity: history, theory, practice. Epidemiol Rev 15: 265-302, 1993.","DOI":"10.1093\/oxfordjournals.epirev.a036121"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32)Oostvogel PM, van Wijngaarden JK, van der Avoort HG, Mulders MN, Conyn-van Spaendonck MA, Rmke HC, van Steenis G, van Loon AM: Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet 344: 665-670, 1994.","DOI":"10.1016\/S0140-6736(94)92091-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33)Kim-Farley RJ, Bart KJ, Schonberger LB, Orenstein WA, Nkowane BM, Hinman AR, Kew OM, Hatch MH, Kaplan JE: Poliomyelitis in the USA: virtual elimination of disease caused by wild virus. Lancet 2: 1315-1317, 1984.","DOI":"10.1016\/S0140-6736(84)90829-8"},{"key":"34","unstructured":"34)CDC: Isolation of wild poliovirus type 3 among members of a religious community objecting to vaccination--Alberta, Canada, 1993. MMWR Morb Mortal Wkly Rep 42: 337-339, 1993."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35)Nathanson N, Kew OM: From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 172: 1213-1229, 2010.","DOI":"10.1093\/aje\/kwq320"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36)Nakano T: Japanese vaccinations and practices, with particular attention to polio and pertussis. Travel Med Infect Dis 9: 169-175, 2011.","DOI":"10.1016\/j.tmaid.2010.05.004"},{"key":"37","unstructured":"37)Tebbens RJ, et al.: Optimal vaccine stockpile design for an eradicated disease: application to polio. Vaccine 28: 4312-4327, 2010."},{"key":"38","unstructured":"38)SAGE Polio Working Group: Proposed policy for a global switch from 'tOPV to bOPV' for routine immunization. Annotated background paper to brief SAGE, April 10, 2012 (http:\/\/www.who.int\/immunization\/sage\/meetings\/2012\/april\/2_Polio_WG_background_paper_26_Mar2012.pdf)"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39)Sutter RW, John TJ, Jain H, Agarkhedkar S, Ramanan PV, Verma H, Deshpande J, Singh AP, Sreevatsava M, Malankar P, Burton A, Chatterjee A, Jafari H, Aylward RB: Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet 376: 1682-1688, 2010.","DOI":"10.1016\/S0140-6736(10)61230-5"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40)Resik S, Tejeda A, Lago PM, Diaz M, Carmenates A, Sarmiento L, Alemani N, Galindo B, Burton A, Friede M, Landaverde M, Sutter RW: Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba. J Infect Dis 201: 1344-1352, 2010.","DOI":"10.1086\/651611"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41)Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MM, Sharif SM, van der Avoort HG, Pallansch MA, Malankar P, Burton A, Sreevatsava M, Sutter RW: Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med 362: 2351-2359. 2010.","DOI":"10.1056\/NEJMoa0909383"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42)Cadorna-Carlos J, Vidor E, Bonnet MC: Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines. Int J Infect Dis 16: e110-116, 2012.","DOI":"10.1016\/j.ijid.2011.10.002"}],"container-title":["Uirusu"],"original-title":["\u30dd\u30ea\u30aa\u30a6\u30a4\u30eb\u30b9\u30ef\u30af\u30c1\u30f3"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T17:41:16Z","timestamp":1621532476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/62\/1\/62_57\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.62.57","relation":{},"ISSN":["0042-6857"],"issn-type":[{"value":"0042-6857","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}